Biospecimen Repository for Interstitial Lung Diseases
This observational study aims to create a collection of blood samples from people with Interstitial Lung Disease (ILD), a group of conditions that cause scarring in the lungs. Researchers will collect 100 cc of blood (about 6-7 tablespoons) from 250 ILD patients, including those with IPF, fibrotic NSIP, and sarcoidosis, among others. They will also collect blood from 25 healthy volunteers and 100 people with pneumonia to compare with the ILD samples. The goal is to build a resource for future studies that will look for markers in the blood to help manage ILD. You may be able to join if you are 18 or older and have been diagnosed with ILD, another fibrotic lung disease, or pneumonia, and are willing to provide a blood sample. The study is currently collecting samples.
- Study design
- This is an observational study that plans to enroll 635 participants. It is not testing a new treatment but rather collecting samples for future research.
- What's involved
- You would provide one blood sample of 100 cc. This is measured at one visit.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Eva M Carmona Porquera, MD, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Future Disease Management1 visit
Reliable biomarkers to help guide treatment in ILD would be a major step forward in the management of this disease.